MilliporeSigma Expands Celonic’s Upstream Capabilities with Mobius® Single-use Bioreactors
Download PDF Read more
Download PDF Read more
Thermo Fisher Scientific Completes Subsequent Offering Period of Tender Offer Following Acquisition of Patheon N.V. WALTHAM, Mass., Sept. 13, 2017 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced the expiration of the subsequent offering period of its previously announced tender offer to purchase all of the outstanding ordinary shares... Read more
Download PDF Read more
Download PDF Read more
Download PDF Read more
Acquisition of Patheon Completed “We’re pleased to complete our acquisition of Patheon and look forward to the significant value this transaction will create for our customers and our shareholders,” said Marc N. Casper, president and chief executive officer of Thermo Fisher Scientific. Read More Read more
High Throughput Mass Spectrometry-Based Clinical Solution Can Run Hundreds of Samples Per Day APHL Newborn Screening and Genetic Testing Symposium, New Orleans, Booth #409– September 8, 2017 – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the launch of its QSight® 210 MD system, designed to provide routine high... Read more
Provides Families a Novel, Personalized Approach to Managing their Health WALTHAM, Massachusetts – September 7, 2017 – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, expanded its Whole Genome Sequencing (WGS) services to families that preserve their cord blood and cord tissue with ViaCord. This launch follows the Company’s recent introduction... Read more
SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ:ILMN) announced today that the company has filed a new patent infringement suit against Premaitha Health plc in the High Court of Justice, Chancery Division, Patents Court in the United Kingdom. Illumina is seeking all available remedies, including damages and injunctive relief. The new suit accuses Premaitha’s IONA® Test of infringing... Read more